Dennis Abraham, MD, medical instructor in the Division of Cardiology, has won the Melvin L. Marcus Young Investigator Award in Basic Cardiovascular Sciences at the AHA Scientific Sessions in Chicago.
The award honors his discovery of TREK-1 as a gene involved in the development of diastolic dysfunction through its affect on cardiac fibrosis. His work identifies a potential novel therapy to target TREK-1 in patients with diastolic heart failure.
Four other finalists for the award gave outstanding presentations, but Abraham's work "stood above the rest," reported Howard Rockman, MD, professor of medicine (Cardiology).
The Melvin L. Marcus Young Investigator Award encourages young investigators to continue research careers in cardiovascular or circulatory physiology. This award has historically recognized physiological research and research in large-mammal studies, and encompasses functional studies in genetically engineered mice or mammals that are the recipients of cell or gene therapy.
Abraham is also a recipient of the Department of Medicine Chair's Research Award.